Date | Time | Source | Headline | Symbol | Company |
07/11/2019 | 09:03 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
07/11/2019 | 02:30 | Edgar (US Regulatory) | Unknown (sec Staff) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
07/11/2019 | 02:30 | Edgar (US Regulatory) | Unknown (sec Staff) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
30/08/2019 | 06:31 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
29/08/2019 | 20:46 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
07/08/2019 | 21:02 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
07/08/2019 | 20:44 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
10/06/2019 | 23:32 | Edgar (US Regulatory) | Certification by the Exchange Approving Securities for Listing (cert) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
08/06/2019 | 06:56 | Edgar (US Regulatory) | Securities Registration (section 12(b)) (8-a12b) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
08/06/2019 | 06:41 | Edgar (US Regulatory) | Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme... | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
08/06/2019 | 06:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
08/06/2019 | 06:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
08/06/2019 | 06:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
08/06/2019 | 06:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
08/06/2019 | 06:14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
08/06/2019 | 06:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
08/06/2019 | 04:20 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
30/05/2019 | 02:58 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
29/05/2019 | 06:10 | GlobeNewswire Inc. | Rexahn Announces Move to Nasdaq | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
13/05/2019 | 22:00 | GlobeNewswire Inc. | Rexahn Pharmaceuticals Reports First Quarter 2019 Financial Results | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
11/05/2019 | 06:22 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
30/04/2019 | 06:45 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
16/04/2019 | 22:04 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
16/04/2019 | 22:00 | GlobeNewswire Inc. | Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
12/04/2019 | 22:16 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
12/04/2019 | 22:00 | GlobeNewswire Inc. | Rexahn Effects 1-for-12 Reverse Stock Split | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
11/04/2019 | 06:07 | GlobeNewswire Inc. | Rexahn Announces Reverse Stock Split | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
27/03/2019 | 23:00 | GlobeNewswire Inc. | Rexahn Announces Multiple Presentations at the 2019 American Association for Cancer Research Annual Meeting | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
27/03/2019 | 07:15 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
11/03/2019 | 21:55 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |